Free Trial 中
Wind ESG Rating

Access to ESG rating for China A-Shares and Hong Kong listed companies.

和元生物

688238.SH
Wind Industry: 医疗保健 > 医药生物 > 生命科学工具和服务Ⅲ > 生命科学工具和服务Ⅳ

公司自2013年成立以来，始终深耕细胞和基因治疗核心领域。公司专注于为细胞和基因治疗的基础研究提供基因治疗载体研制、基因功能研究、药物靶点及药效研究等CRO服务；为细胞与基因治疗药物的研发提供工艺开发及测试、IND-CMC药学研究、临床样品及商业化产品的GMP生产等CDMO服务；为再生医学及抗衰领域提供细胞制备、重组蛋白/外泌体等细胞衍生物生产、细胞存储等技术服务。致力于推动细胞和基因治疗及相关健康产业的技术开发及转化应用，造福生命健康。公司秉承“整合你我资源，服务生命科学”的理念，坚守“客户第一、高效执行、追求卓越、创新突破、诚信务实”的价值观，已成长为一家集基因功能基础研究服务、临床级细胞与基因治疗药物商业化生产服务、再生医学服务三大发展方向于一体的高新技术企业。

ESG Score Industry Ranking:
6 / 36 (生命科学工具和服务Ⅲ)

ESG Rating Distribution(生命科学工具和服务Ⅲ)

Trend of Rating

2022-08-01: BB; 2023-08-01: BB; 2024-08-01: BB; 2025-05-16: A; 2026-07-01: AA BB2022.08 BB2023.08 BB2024.08 A2025.05 AA2026.07

About Wind ESG Rating

Wind has developed a rigorous rating methodology based on the core connotations of ESG, aligning with international standards and frameworks, and incorporating the characteristics of Chinese companies, to assess the company's essential ESG performance, risk and its ability to operate sustainably.

Focusing on the ESG risks and opportunities of each industry, the companies are rated on a AAA-CCC scale relative to the performance of their industry peers. Wind ESG rating is updated annually or in response to major changes.

The Wind ESG Rating Issuer Communication Platform (esg.wind.com.cn) is now available. Rated companies can access their detailed rating information through this platform, and communicate with or provide feedback to the Wind ESG Rating team regarding specific rating components. For any additional questions, please feel free to send an email to GR.ESG@wind.com.cn.

ESG Score

ESG Score：8.21Updated on 2026-10-29
08.2110
Management & Practices Score：5.43Updated on 2026-09-16
05.437
Controversies Score：2.78Updated on 2026-10-29
02.783

ESG Score Comparison

Environmental Social Governance 和元生物生命科学工具和服务Ⅲ Average
IndicatorCompany ScoreIndustry AverageWeight
Environmental4.783.7915.43%
Social8.615.1558.35%
Governance7.586.3326.22%

Wind ESG Rating Framework

Building on the foundation of domestic and international ESG policies and standards, our proprietary ESG rating framework considers the development of Chinese capital market and integrates the characteristics of the Chinese companies in various industries. The Wind ESG Rating framework is composed of management & practice and controversies assessment, including:

  • 500+ management & practices indicators, covering E, S and G pillars, reflecting long-term ESG fundamental impacts
  • 1,200+ risk labels, covering news, regulatory penalties and lawsuits, reflecting impact of short-term risks

Management & practice score is the weighted summation of E, S and G pillar scores. The weights reflect both the relative impact of each issue within each industry and the negative or positive contribution of each industry to the environment and society relative to other industries.

Controversies score and ESG score are updated daily, E, S and G pillar scores and management & practice score are updated with underlying data, corresponding data are released on various channels, including Wind Financial Terminal.

Explore More

Wind ESG Rating Methodology.pdf1,198KB Wind ESG Ratings FAQs.pdf755KB
More Details

Peer Comparison(36 companies in the industry) ?

RankingCodeSecurity NameESG RatingESG ScoreControversies ScoreManagement & Practices ScoreEnvironmentalSocialGovernance
1688114.SH华大智造AA8.822.985.856.928.778.25
2300725.SZ药石科技AA8.523.005.528.877.338.55
3002821.SZ凯莱英A8.442.985.476.417.968.30
4301230.SZ泓博医药AA8.332.975.366.798.137.13
5688131.SH皓元医药AA8.312.995.316.307.847.79
6688238.SH和元生物AA8.212.785.434.788.617.58
7688202.SH美迪西AA8.192.975.225.247.937.68
8688222.SH成都先导AA8.112.995.126.027.597.46
9300759.SZ康龙化成AA8.052.935.127.677.436.83
9603259.SH药明康德AA8.052.995.077.746.568.46